123 related articles for article (PubMed ID: 25915411)
1. Construction of a BALB/c-Nu Mouse Model of Invasive Bladder Carcinoma and Preliminary Studies on the Treatment of Bladder Tumors through Internal Iliac Arterial Infusion of Albumin-Bound Arsenic Trioxide (As2O3).
Li Y; Yu G; Li Q; Wang W; Shen X; Liu H; Liu R
PLoS One; 2015; 10(4):e0124959. PubMed ID: 25915411
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral injection of arsenic to enhance antitumor efficacy in human esophageal carcinoma cell xenografts.
Shen ZY; Zhang Y; Chen JY; Chen MH; Shen J; Luo WH; Zeng Y
Oncol Rep; 2004 Jan; 11(1):155-9. PubMed ID: 14654919
[TBL] [Abstract][Full Text] [Related]
3. Preparation of arsenic trioxide-loaded albuminutes immuno-nanospheres and its specific killing effect on bladder cancer cell in vitro.
Zhou J; Zeng FQ; Li C; Tong QS; Gao X; Xie SS; Yu LZ
Chin Med J (Engl); 2005 Jan; 118(1):50-5. PubMed ID: 15642226
[TBL] [Abstract][Full Text] [Related]
4. [Primary study of arsenic trioxide inhibits abdomino-metastatic tumor formation of human ovarian carcinoma in nude mice and its mechanisms].
Huang SG; Kong BH; Yang RF; Jiang S
Ai Zheng; 2002 Apr; 21(4):401-4. PubMed ID: 12452020
[TBL] [Abstract][Full Text] [Related]
5. The inhibition of growth and angiogenesis in heterotransplanted esophageal carcinoma via intratumoral injection of arsenic trioxide.
Shen ZY; Shen J; Chen MH; Wu XY; Wu MH; Zeng Y
Oncol Rep; 2003; 10(6):1869-74. PubMed ID: 14534710
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide (As2O3) sensitivity of carcinoma cell lines and cancer cells from patients with carcinomatosis peritonei.
Moon Y; Park G; Kim Y; Kim M; Lim J; Pai SH; Lee EJ; Kang CS; Han K
Ann Clin Lab Sci; 2004; 34(3):271-6. PubMed ID: 15487701
[TBL] [Abstract][Full Text] [Related]
7. Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models.
Hines-Peralta A; Sukhatme V; Regan M; Signoretti S; Liu ZJ; Goldberg SN
Radiology; 2006 Jul; 240(1):82-9. PubMed ID: 16720872
[TBL] [Abstract][Full Text] [Related]
8. Synergic effect of 3'-azido-3'-deoxythymidine and arsenic trioxide in suppressing hepatoma cells.
Chen C; Zhang Y; Wang Y; Huang D; Xi Y; Qi Y
Anticancer Drugs; 2011 Jun; 22(5):435-43. PubMed ID: 21502917
[TBL] [Abstract][Full Text] [Related]
9. [Arsenic trioxide induces differentiation of human nasopharyngeal carcinoma in BALB/C nude mice xenograft model].
Du CW; Li DR; Lin YC; Wu MY
Ai Zheng; 2003 Jan; 22(1):21-5. PubMed ID: 12561430
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide inhibits lung metastasis of mouse colon cancer via reducing the infiltration of regulatory T cells.
Wang L; Hu X; Xu Y; Liu Z
Tumour Biol; 2016 Nov; 37(11):15165-15173. PubMed ID: 27677289
[TBL] [Abstract][Full Text] [Related]
11. Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice.
Liu B; Pan S; Dong X; Qiao H; Jiang H; Krissansen GW; Sun X
Cancer Sci; 2006 Jul; 97(7):675-81. PubMed ID: 16827809
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect and mechanisms of arsenic trioxide on subcutaneously implanted human gastric cancer in nude mice.
Wu DD; Xiao YF; Geng Y; Hou J
Cancer Genet Cytogenet; 2010 Apr; 198(2):90-6. PubMed ID: 20362223
[TBL] [Abstract][Full Text] [Related]
13. Anticancer effect of arsenic trioxide on cholangiocarcinoma: in vitro experiments and in vivo xenograft mouse model.
Kim EY; Lee SS; Shin JH; Kim SH; Shin DH; Baek SY
Clin Exp Med; 2014 May; 14(2):215-24. PubMed ID: 23467906
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide re-sensitizes ERα-negative breast cancer cells to endocrine therapy by restoring ERα expression in vitro and in vivo.
Zhang W; Wang L; Fan Q; Wu X; Wang F; Wang R; Ma Z; Yang J; Lu SH
Oncol Rep; 2011 Sep; 26(3):621-8. PubMed ID: 21687957
[TBL] [Abstract][Full Text] [Related]
16. [Anti-angiogenesis effect of arsenic trioxide plus cinobufacin on human hepatocarcinoma transplantation model nude mice].
Liu L; Chen BA; Qin SK
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jan; 31(1):67-72. PubMed ID: 21434348
[TBL] [Abstract][Full Text] [Related]
17. Effects of Tat peptide on intracellular delivery of arsenic trioxide albumin microspheres.
Zhou J; Wang QH; Liu JH; Wan YB
Anticancer Drugs; 2012 Mar; 23(3):303-12. PubMed ID: 22123336
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitory effect of arsenic trioxide combined with cisplatin on human nasopharyngeal carcinoma xenograft and DAPK in nude mice].
Huang X; Wang X; Hu J; Zhou H; Zhou K; Zhang Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 May; 27(9):479-83. PubMed ID: 23898615
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of arsenic trioxide to transitional carcinoma cells.
Pu YS; Hour TC; Chen J; Huang CY; Guan JY; Lu SH
Urology; 2002 Aug; 60(2):346-50. PubMed ID: 12137851
[TBL] [Abstract][Full Text] [Related]
20. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
